224 related articles for article (PubMed ID: 14709568)
1. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Price D
JAMA; 2004 Jan; 291(1):40-1; author reply 42. PubMed ID: 14709568
[No Abstract] [Full Text] [Related]
2. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Spielmans GI
JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
[No Abstract] [Full Text] [Related]
3. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Solyom AE
JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
[No Abstract] [Full Text] [Related]
4. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
Mathews M; Mathews M; Mathews J
JAMA; 2004 Jan; 291(1):40; author reply 42. PubMed ID: 14709567
[No Abstract] [Full Text] [Related]
5. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents.
Newcorn JH
Curr Psychiatry Rep; 2004 Apr; 6(2):85-7. PubMed ID: 15038909
[No Abstract] [Full Text] [Related]
6. Sertraline and depression in children.
Garland EJ
JAMA; 2004 Apr; 291(13):1561; author reply 1561-2. PubMed ID: 15069038
[No Abstract] [Full Text] [Related]
7. Psychopharmacological treatment of major depressive disorder in children and adolescents.
Varley CK
JAMA; 2003 Aug; 290(8):1091-3. PubMed ID: 12941683
[No Abstract] [Full Text] [Related]
8. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
[TBL] [Abstract][Full Text] [Related]
9. Which SSRIs most effectively treat depression in adolescents?
DeLucia V; Kelsberg G; Safranek S
J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
[TBL] [Abstract][Full Text] [Related]
10. Depression management programs.
Dietrich AJ
Arch Fam Med; 2000 Aug; 9(8):689-70. PubMed ID: 10927701
[No Abstract] [Full Text] [Related]
11. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
12. Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report.
Ghanizadeh A
Neuro Endocrinol Lett; 2008 Dec; 29(6):877-8. PubMed ID: 19112394
[TBL] [Abstract][Full Text] [Related]
13. Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report.
Khawaja IS; Hurwitz TD; Schenck CH
J Clin Psychiatry; 2008 Dec; 69(12):1982-3. PubMed ID: 19203482
[No Abstract] [Full Text] [Related]
14. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors in children and adolescents with major depression.
Scahill L
Braz J Psychiatry; 2005 Jun; 27(2):91-2. PubMed ID: 15962129
[No Abstract] [Full Text] [Related]
16. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
Finkel SI; Richter EM; Clary CM; Batzar E
Am J Geriatr Psychiatry; 1999; 7(3):221-7. PubMed ID: 10438693
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Liao XM; Su YA; Wang Y; Yu X; Si TM
Chin Med J (Engl); 2020 Mar; 133(6):726-728. PubMed ID: 32097208
[No Abstract] [Full Text] [Related]
18. Relapse of depressive symptoms after discontinuing sertraline.
Baldessarini RJ; Viguera AC
JAMA; 1999 Jul; 282(4):323-4. PubMed ID: 10432022
[No Abstract] [Full Text] [Related]
19. Psychomotor changes in major depressive disorder during sertraline treatment.
Schrijvers D; Maas YJ; Pier MP; Madani Y; Hulstijn W; Sabbe BG
Neuropsychobiology; 2009; 59(1):34-42. PubMed ID: 19270462
[TBL] [Abstract][Full Text] [Related]
20. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
Malinina EV; Zabozlaeva IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):22-4. PubMed ID: 20823825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
